VITA Full Transcriptome Profiling Services Available at the University of California's Genomics and Bioinformatics Technology Center
Los Angeles, CA – M20 Genomics is pleased to announce the installation of its VITA Single-Cell Full-Length Transcriptome Platform [Link] at the Genomics and Bioinformatics Technology Center (TCGB) [Link] at the University of California, Los Angeles (UCLA). This collaboration significantly enhances the spectrum of tools available to local research teams, enabling transcriptomic profiling in various sample types and species with single-cell resolution.
VITA platform at the TCGB at the UCLA.
Revolutionizing Transcriptome Analysis with VITA at TCGB
Utilizing M20 Genomics‘ innovative random primer-based M20 Seq technology, the VITA platform provides unparalleled sample coverage. It accommodates a wide range of sample types, including fresh, frozen, and FFPE samples. Its unique capabilities extend to a diverse array of biological species, from eukaryotes to bacteria, and it is particularly designed for processing complex microbial samples such as gut microbiota. This paves the way for novel insights in various research fields, from cancer research to microbiology.
With the installation of the VITA Platform our technical experts have delivered extensive, in-depth training to the TCGB team. Covering every critical aspect of the workflow—from sample preparation to advanced data analysis—this extensive training ensures that the TCGB team is exceptionally equipped to leverage the full potential of the VITA platform.
Hands-on training session by M20 Genomics‘ technical experts at TCGB.
The TCGB now offers comprehensive transcriptome profiling services for the VITA platform. Our strategic cooperation combines M20 Genomics' cutting-edge technologies with the outstanding expertise of TCGB, providing the tools and support to elevate your research and achieve scientific breakthroughs.
About Technology Center for Genomics & Bioinformatics (TCGB)
The Technology Center for Genomics & Bioinformatics (TCGB) is a fully automated, high-throughput genomic Center equipped with all major next generation sequencing. TCGB provides state-of-the-art genomics technologies, comprehensive services, specialized expertise and a wide range of trainings, enabling these services in a cost-effective and timely manner to serve basic science and translational/clinical research. In addition, TCGB provides pre-experiment consultation and post-experiment support, including preparation of grant applications, publications, and strategic planning for additional research steps. TCGB also provides educational training to faculty, staff, and students to raise awareness of new directions and major discoveries in the areas of genomics and bioinformatics.
About M20 Genomics
M20 Genomics is a rapidly growing life science technology company dedicated to pushing the boundaries of single-cell and spatial technologies. Our mission is to empower our customers by overcoming technological barriers in cutting-edge single-cell and spatial technologies, unraveling mysteries in life science, and driving advancements in disease diagnosis and treatment. With M20 Seq technology, we have pioneered the world's first high-throughput full-length single-cell technology sequencing using random primers, along with our VITA product line for single-cell transcriptome sequencing. In addition, our M20 Spatial technology, utilizing random primers and paired with our NATA spatial transcriptome product line, provides the first spatial full-transcriptome solution across various sample types. To learn more about our transformative technologies, visit the M20 Genomics website or follow us on LinkedIn or X.
